SIX4 Antibody

What is SIX4 protein and why is it important in research?

SIX4 (SIX homeobox 4) is a transcriptional regulator belonging to the Six/Sine oculis homeobox family. It functions as both a transcriptional repressor and activator by binding to specific DNA sequences on target genes. SIX4 is involved in critical cellular processes including differentiation, migration, and survival . It plays essential roles in the development of multiple organs, particularly in muscle development, where it regulates various steps from myogenic progenitor genesis to myofiber specialization . SIX4's significance in research stems from its involvement in developmental processes and its emerging roles in pathological conditions such as cancer, making it a valuable target for developmental biology and disease research.

What are the key characteristics of SIX4 protein that researchers should be aware of?

SIX4 is a 760 amino acid nuclear protein with a molecular weight of approximately 82.9-83 kDa, although it often appears around 98 kDa in Western blots due to post-translational modifications . It contains a conserved DNA-binding domain characteristic of the Six/Sine oculis homeobox family and exhibits approximately 90% sequence similarity with its mouse counterpart . SIX4 binds to specific DNA motifs including the 5'-[CAT]A[CT][CT][CTG]GA[GAT]-3' sequence in the Trex site and the 5'-TCA[AG][AG]TTNC-3' sequence in the MEF3 site of muscle-specific gene enhancers . SIX4 acts cooperatively with EYA proteins to transactivate target genes through interaction and nuclear translocation of EYA protein . Researchers should note that SIX4 may also be known by alternative names including AREC3, homeobox protein SIX4, and sine oculis homeobox homolog 4 .

What experimental applications are SIX4 antibodies suitable for?

SIX4 antibodies are suitable for multiple research applications, with varying specificities and optimal conditions depending on the specific antibody clone. The main applications include:

It's important to note that the optimal working concentration varies between different antibody products and should be determined empirically for each experimental system .

How can I validate the specificity of my SIX4 antibody for research applications?

Validating SIX4 antibody specificity is crucial for reliable research results. A comprehensive validation approach includes:

• Knockdown/Knockout Validation: Use siRNA or CRISPR to reduce SIX4 expression and confirm reduced signal in Western blots or other applications. This is considered the gold standard for antibody validation . Several publications have demonstrated this approach with specific SIX4 antibodies, showing reduced signal intensity following SIX4 knockdown .

• Overexpression Analysis: Compare signal between cells with endogenous expression and those overexpressing SIX4. An increase in signal intensity at the expected molecular weight supports antibody specificity.

• Cross-reactivity Testing: Test the antibody against samples from multiple species if cross-reactivity is claimed. Verify that the observed molecular weight matches the predicted species-specific weight of SIX4.

• Antigen Competition: Pre-incubate the antibody with its immunizing peptide before application. This should eliminate specific binding if the antibody is truly specific.

• Multiple Antibody Confirmation: Use different antibodies targeting distinct epitopes of SIX4 to confirm the observed patterns, especially in imaging applications.

For SIX4 specifically, researchers should be aware that the observed molecular weight is often around 98 kDa in Western blots, despite a calculated weight of approximately 83 kDa . This discrepancy is likely due to post-translational modifications.

What are the optimal sample preparation methods for detecting SIX4 in different experimental systems?

Optimal sample preparation for SIX4 detection varies by application:

For Western Blotting:

• Use fresh cell lysates prepared with RIPA buffer containing protease inhibitors

• Include phosphatase inhibitors if studying SIX4 phosphorylation status

• Denature samples at 95°C for 5 minutes in standard Laemmli buffer

• Load 20-50 μg of total protein per lane on 8-10% SDS-PAGE gels for optimal resolution of SIX4's 83-98 kDa band

• Transfer to PVDF membranes (rather than nitrocellulose) for better retention of higher molecular weight proteins

For Immunohistochemistry:

• Use formalin-fixed, paraffin-embedded (FFPE) tissues sectioned at 4-6 μm thickness

• For optimal SIX4 detection, perform antigen retrieval with TE buffer at pH 9.0, though citrate buffer at pH 6.0 can serve as an alternative

• Block with 5% normal serum (corresponding to the secondary antibody host) in PBS for 1 hour at room temperature

• Dilute primary SIX4 antibody appropriately (typically 1:250-1:1000) in blocking buffer

For Immunofluorescence:

• Fix cells with 4% paraformaldehyde for 15 minutes at room temperature

• Permeabilize with 0.1-0.5% Triton X-100 in PBS for 10 minutes

• Block with 5% BSA in PBS for 1 hour at room temperature

• Dilute SIX4 antibody 1:50-1:500 depending on the specific antibody

• Include a nuclear counterstain (e.g., DAPI) to confirm SIX4's nuclear localization

How can I troubleshoot weak or non-specific signals when using SIX4 antibodies?

When encountering issues with SIX4 antibody performance, consider these troubleshooting approaches:

For Weak Signals:

• Antibody Concentration: Increase primary antibody concentration incrementally (e.g., from 1:1000 to 1:500)

• Incubation Time: Extend primary antibody incubation time (overnight at 4°C instead of 1-2 hours)

• Detection System: Switch to more sensitive detection systems (e.g., from colorimetric to chemiluminescent for Western blots)

• Sample Amount: Increase protein loading for Western blots (up to 50-100 μg)

• Antigen Retrieval: For IHC, optimize antigen retrieval conditions (try TE buffer pH 9.0 as recommended specifically for SIX4)

• Sample Preservation: Ensure proper sample handling to prevent protein degradation (use fresh samples and include protease inhibitors)

For Non-specific Signals:

• Blocking Optimization: Increase blocking time or concentration (e.g., from 5% to 10% BSA or milk)

• Antibody Dilution: Use more diluted antibody solution to reduce non-specific binding

• Washing Steps: Increase number and duration of washing steps

• Secondary Antibody: Ensure appropriate species-matching of secondary antibody

• Negative Controls: Include samples with knocked-down SIX4 expression or secondary-only controls

• Antibody Selection: Consider switching to monoclonal antibodies like clone D-5 or 7E2 which tend to have higher specificity

How is SIX4 expression regulated in cancer models, and what roles does it play in tumor progression?

SIX4 exhibits complex regulation and functions in cancer models:

Epigenetic Regulation:
Recent studies reveal that SIX4 expression is inversely correlated with its promoter methylation, particularly in estrogen receptor-positive breast cancer . Low SIX4 promoter methylation leads to high SIX4 expression, suggesting epigenetic regulation as a key control mechanism.

Inflammatory Regulation:
In colorectal cancer models, SIX4 activation occurs during inflammation induction, driving the transformation of colorectal epithelium into inflammatory and tumorigenic states . This activation involves an IL-6/STAT3/SIX4/c-JUN feedback loop that promotes cancer development.

Functional Roles in Cancer:

• Tumor Stemness: SIX4 induces DeltaNp63 expression by binding to its promoter, thereby activating tumor stemness signals that contribute to colorectal cancer formation .

• Immune Suppression: High SIX4 expression is associated with decreased immune infiltration in tumors, suggesting an immunosuppressive role that may contribute to tumor evasion of immune surveillance .

• Disease Progression: Increased SIX4 expression correlates with advanced cancer stage and poor survival outcomes, particularly in estrogen receptor-positive breast cancer patients .

Therapeutic Potential:
SIX4 has emerged as a promising therapeutic target in inflammatory bowel disease (IBD) and colitis-associated colorectal cancer (CAC). In vivo studies show that targeting SIX4 with siRNA therapy (30 μg administered intraperitoneally three times weekly) attenuates the transformation of inflammation to cancer in intestinal epithelium .

What experimental approaches are most effective for studying SIX4 knockdown effects in disease models?

Studying SIX4 knockdown effects in disease models requires careful experimental design:

In Vitro Approaches:

• siRNA Transfection: Use Lipofectamine 3000 for transient SIX4 knockdown in cancer cell lines like SW480 and HT29. This approach has successfully demonstrated SIX4's role in promoting tumor stemness via DeltaNp63 activation .

• Stable Lentiviral shRNA: For long-term studies, establish stable cell lines expressing SIX4 shRNA using lentiviruses labeled with GFP at an MOI of 20. Selection with 8 ng/ml puromycin can ensure maintenance of the knockdown .

• Functional Assays: Following knockdown, assess proliferation, migration, invasion, and spheroid formation to understand SIX4's contributions to cancer hallmarks.

In Vivo Approaches:

• AOM/DSS Model: The azoxymethane/dextran sodium sulfate (AOM/DSS) model effectively recapitulates colitis-associated colon cancer, showing significant SIX4 upregulation that can be targeted therapeutically .

• In Vivo siRNA Delivery: Formulate SIX4 siRNA (30 μg) with in vivo-jetPEI and administer intraperitoneally three times weekly. This approach has demonstrated efficacy in reducing cancer progression in mouse models .

• Phenotypic Assessment: Monitor disease activity index (DAI) including body weight loss, stool consistency, and occult blood to evaluate therapeutic efficacy.

Validation and Mechanistic Studies:

• Protein Expression Analysis: Confirm knockdown efficiency using Western blotting with validated SIX4 antibodies .

• Transcriptional Analysis: Perform RNA-seq to identify genes differentially regulated upon SIX4 knockdown.

• Chromatin Immunoprecipitation (ChIP): Use SIX4 antibodies suitable for IP to identify direct genomic targets of SIX4, particularly in regulatory regions of genes like DeltaNp63 .

• Reporter Assays: Implement dual-luciferase reporter assays with wild-type or mutant promoter sequences of putative SIX4 target genes to confirm direct transcriptional regulation .

How can I design effective ChIP-seq experiments to identify SIX4 binding sites in the genome?

Designing effective ChIP-seq experiments for SIX4 requires attention to several critical factors:

Antibody Selection and Validation:

• Choose highly specific SIX4 antibodies validated for immunoprecipitation applications. Antibodies like those from Bethyl Laboratories have been specifically recommended for IP applications with SIX4 .

• Validate the antibody's IP efficiency using a pilot IP-Western blot experiment before proceeding to ChIP-seq.

• Confirm specificity through knockdown controls, where SIX4 depletion should significantly reduce IP signal .

Experimental Design:

• Crosslinking: Use 1% formaldehyde for 10 minutes at room temperature for optimal DNA-protein crosslinking.

• Sonication: Optimize sonication conditions to generate DNA fragments of 200-500 bp. For SIX4, which binds to specific DNA motifs like 5'-[CAT]A[CT][CT][CTG]GA[GAT]-3' and 5'-TCA[AG][AG]TTNC-3', proper fragmentation is crucial .

• IP Protocol: Use 5-10 μg of SIX4 antibody per ChIP reaction with magnetic beads for immunoprecipitation.

• Controls: Include input DNA (pre-IP sample), IgG control (non-specific antibody), and ideally a SIX4-depleted sample.

Data Analysis Considerations:

• Align sequences to the reference genome using appropriate algorithms that account for SIX4's binding preference to gene regulatory regions.

• Use peak-calling algorithms with parameters suitable for transcription factors.

• Perform motif enrichment analysis to confirm enrichment of known SIX4 binding motifs like the MEF3 site .

• Integrate with RNA-seq data from SIX4 knockdown experiments to correlate binding with transcriptional regulation.

Validation of ChIP-seq Results:

• Confirm selected binding sites with ChIP-qPCR using different SIX4 antibodies.

• Validate functional significance through reporter assays with wild-type and mutant binding sites, as demonstrated in studies of SIX4's regulation of DeltaNp63 .

• Perform functional studies (knockdown/overexpression) of SIX4 to correlate binding with gene expression changes.

What are the best experimental designs for investigating SIX4 protein-protein interactions?

Investigating SIX4 protein-protein interactions requires multiple complementary approaches:

Co-Immunoprecipitation (Co-IP):

• Antibody Selection: Use SIX4 antibodies validated for IP applications, such as those from Bethyl Laboratories or Santa Cruz (D-5 clone) .

• Lysis Conditions: Use gentler lysis buffers (containing 0.5% NP-40 rather than SDS) to preserve protein interactions.

• Validation: Perform reciprocal Co-IPs (pull down with SIX4 antibody and probe for partner, then vice versa) for robustness.

• Controls: Include IgG controls and SIX4-knockdown samples to confirm specificity.

This approach has successfully identified SIX4's interactions with EYA proteins, demonstrating how SIX4 acts cooperatively with EYA to transactivate target genes .

Proximity Ligation Assay (PLA):

• Use validated SIX4 antibodies raised in different host species from antibodies against putative interaction partners.

• Optimize fixation and permeabilization to preserve both SIX4's nuclear localization and its interactions.

• Include controls with single antibodies and non-interacting protein pairs.

This technique is particularly valuable for confirming interactions in situ within cellular contexts.

Bimolecular Fluorescence Complementation (BiFC):

• Create fusion constructs of SIX4 and potential partners with split fluorescent protein fragments.

• Transfect into appropriate cell models and assess fluorescence complementation.

• Include appropriate negative controls with proteins known not to interact with SIX4.

This approach can reveal the subcellular localization of interactions in living cells.

Functional Validation:

• Luciferase Reporter Assays: Test the functional consequence of interactions on transcriptional activity using reporter constructs with SIX4 binding sites, as done in studies of SIX4's interaction with STAT3 in colorectal cancer models .

• Domain Mapping: Generate truncated SIX4 constructs to map interaction domains, particularly focusing on the Six domain which serves as a homeobox DNA-binding motif .

• Post-translational Modifications: Investigate how modifications affect interactions using phospho-specific antibodies or phosphatase treatments.

How can I effectively use SIX4 antibodies in multiplex immunofluorescence studies to investigate its role in tissue contexts?

Multiplex immunofluorescence with SIX4 antibodies requires careful optimization:

Antibody Selection and Validation:

• Choose SIX4 antibodies validated specifically for immunofluorescence applications, such as D-5 clone (sc-390779 FITC) or polyclonal antibodies with demonstrated IF reactivity .

• Verify antibody performance in single-staining experiments before multiplexing.

• Test for cross-reactivity with other primary and secondary antibodies to be used in the multiplex panel.

• Include proper controls: positive control tissues known to express SIX4 (e.g., muscle tissue), negative controls (secondary antibody only), and if possible, SIX4-knockdown samples.

Panel Design Considerations:

• Compatible Primary Antibodies: Select antibodies raised in different host species to avoid cross-reactivity.

• Marker Selection: Choose markers relevant to SIX4 biology, such as:

  • Developmental markers: PAX3, MYF5, MYOD1 (for muscle development studies)

  • Cancer-related markers: DeltaNp63, STAT3, IL-6 (for cancer studies)

  • Cell-type specific markers to identify SIX4-expressing cells in heterogeneous tissues

• Fluorophore Selection: Choose fluorophores with minimal spectral overlap and appropriate brightness for each target's abundance. For SIX4, which is a nuclear protein, brighter fluorophores may be needed if expression is moderate.

Optimized Protocol:

• Sequential Staining: For difficult combinations, use sequential staining with complete elution between rounds rather than simultaneous staining.

• Antigen Retrieval: For FFPE tissues, use TE buffer at pH 9.0 for optimal SIX4 detection .

• Signal Amplification: Consider tyramide signal amplification for low-abundance targets.

• Nuclear Counterstain: Include DAPI to confirm SIX4's nuclear localization.

• Automated Analysis: Implement tissue cytometry software for quantitative analysis of co-expression patterns.

Advanced Applications:

• Spatial Transcriptomics Integration: Combine multiplex IF with spatial transcriptomics to correlate SIX4 protein expression with transcriptional profiles.

• Serial Sectioning: Perform serial section staining when antibody incompatibilities prevent direct multiplexing.

• 3D Reconstruction: For developmental studies, consider 3D reconstruction from z-stack imaging to understand SIX4's spatial relationships in tissues like developing muscle or neural tissue.

How can researchers effectively use SIX4 antibodies to study its role in muscle development and regeneration?

SIX4 plays critical roles in muscle development and regeneration, making it an important target for developmental biology research:

Key Developmental Stages for SIX4 Investigation:

• Hypaxial Progenitor Genesis: SIX4 controls the genesis of hypaxial myogenic progenitors in the dermomyotome by transactivating PAX3 .

• Progenitor Migration: SIX4 regulates the delamination and migration of hypaxial precursors from the ventral lip to the limb buds through transactivation of PAX3, MET, and LBX1 .

• Myoblast Determination: SIX4 controls myoblast determination by transactivating MYF5, MYOD1, and MYF6 .

• Fiber Specialization: SIX4 participates in myofiber specialization during embryogenesis by activating the fast muscle program in the primary myotome .

• Regeneration: During muscle regeneration, SIX4 negatively regulates differentiation of muscle satellite cells through down-regulation of MYOG expression .

Experimental Approaches:

• Developmental Timing Analysis:

  • Use SIX4 antibodies in combination with stage-specific markers to track temporal expression patterns during muscle development

  • Implement tissue clearing techniques with immunofluorescence to visualize SIX4 expression in whole embryo sections

  • Correlate SIX4 expression with critical developmental transitions

• Cell-Type Specific Analysis:

  • Perform co-staining with PAX3, MET, and LBX1 to identify migratory progenitor populations

  • Use multiplex immunofluorescence to simultaneously detect SIX4 with MYF5, MYOD1, and MYF6 in determining myoblasts

  • Identify fiber-type specific expression patterns by co-staining with fast muscle markers (ATP2A1, MYL1, TNNT3) and slow muscle regulatory factors (SOX6, HRASLS, HDAC4)

• Regeneration Studies:

  • In muscle injury models, track SIX4 expression in satellite cells using co-staining with satellite cell markers

  • Correlate SIX4 levels with MYOG expression during different phases of regeneration

  • Implement SIX4 knockdown approaches to assess functional consequences on regenerative capacity

Methodological Considerations:

• Use antibodies validated specifically for mouse or rat samples when studying developmental models

• For embryonic studies, optimize fixation protocols to preserve tissue architecture while maintaining antibody reactivity

• Consider whole-mount immunostaining for early embryonic stages to maintain spatial relationships

• Implement quantitative image analysis to measure nuclear SIX4 levels during different developmental stages

What approaches can be used to investigate contradictory findings about SIX4 function across different cell types or developmental contexts?

Researchers often encounter contradictory findings about SIX4 function across different biological contexts. Here are systematic approaches to address these contradictions:

Context-Specific Expression Analysis:

• Quantitative Comparison: Use validated SIX4 antibodies for Western blot analysis to quantitatively compare SIX4 expression levels across different cell types and developmental stages .

• Isoform Detection: Implement antibodies targeting different SIX4 epitopes to determine if distinct isoforms are expressed in different contexts. Compare N-terminal versus C-terminal targeting antibodies to identify potential truncated variants .

• Post-translational Modifications: Use phospho-specific antibodies or combine immunoprecipitation with mass spectrometry to identify context-specific post-translational modifications that may alter SIX4 function.

Functional Domain Analysis:

• Domain-Specific Antibodies: Use antibodies targeting specific functional domains of SIX4 (DNA-binding domain versus transactivation domain) to assess domain accessibility in different contexts .

• Mutational Analysis: Generate domain-specific mutants and assess their function in different cell types to identify context-dependent requirements for specific domains.

• Protein-Protein Interaction Comparison: Use Co-IP with SIX4 antibodies to identify different binding partners across cell types that may explain context-specific functions .

Transcriptional Target Analysis:

• ChIP-seq Comparison: Perform comparative ChIP-seq using SIX4 antibodies in different cell types to identify context-specific genomic binding sites.

• Reporter Assays: Test the activity of SIX4 on known target promoters (e.g., PAX3, MYOD1, DeltaNp63) across different cell types to quantify context-specific transcriptional regulation .

• Motif Analysis: Analyze the flanking sequences of SIX4 binding sites to identify potential co-factor binding motifs that might explain differential activity.

Integrative Approaches:

• Combined Knockdown-Rescue Experiments: Knock down endogenous SIX4 and rescue with either wild-type or domain mutants to identify the functional requirements in different contexts .

• Co-factor Manipulation: Simultaneously manipulate SIX4 and potential co-factors (like EYA proteins) to determine if contradictory functions stem from differential co-factor availability .

• Temporal Control Systems: Use inducible knockdown or overexpression systems to distinguish between direct and indirect effects of SIX4 manipulation .

Data Interpretation Framework:

• Develop a unified model incorporating developmental timing, cellular context, and co-factor availability to explain apparently contradictory functions

• Distinguish between SIX4's roles as a pioneer factor in development versus its maintenance functions in differentiated tissues

• Consider redundancy with other SIX family members (SIX1, SIX2) that may compensate differently across contexts